Initial sitagliptin plus metformin demonstrated to be effective in patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2007年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：562 / 562
页数：1
相关论文
共 50 条
  • [1] Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes
    Williams-Herman, D.
    Xu, L.
    Teng, R.
    Golm, G. T.
    Johnson, J.
    Davies, M. J.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 67 - 76
  • [2] AN OBSERVATIONAL STUDY COMPARING SITAGLIPTIN TO METFORMIN AS A INITIAL MONOTHERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS
    Riyaz, Mohd.
    Imran
    Manuel, Rinu
    Joseph, Nidhisha K.
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (07): : 1698 - 1703
  • [3] Achievement of weight loss with canagliflozin, sitagliptin and glimepiride in combination with metformin or metformin plus sulfonylurea in patients with Type 2 diabetes
    Stein, L.
    Thompson, G.
    Diels, J.
    Thilakarathne, P.
    Girod, I.
    [J]. DIABETIC MEDICINE, 2014, 31 : 145 - 145
  • [4] Sitagliptin/metformin (Janumet) for type 2 diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1262): : 45 - 47
  • [5] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Yolanda
    Zhao, June
    Pan, Changyu
    [J]. DIABETES, 2017, 66 : A327 - A327
  • [6] FOUR YEAR OUTCOME OF INITIAL COMBINATION OF SITAGLIPTIN AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN REAL CLINICAL PRACTICE
    Ku, E. J.
    Jung, K. Y.
    Kim, Y. J.
    Kim, K. M.
    Moon, J. H.
    Choi, S. H.
    Park, K. S.
    Jang, H. C.
    Cho, Y. M.
    Lim, S.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S139 - S140
  • [7] Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
    Williams-Herman, D.
    Johnson, J.
    Teng, R.
    Golm, G.
    Kaufman, K. D.
    Goldstein, B. J.
    Amatruda, J. M.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (05): : 442 - 451
  • [8] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [9] COST CONSEQUENCE ANALYSIS OF SITAGLIPTIN plus METFORMIN VS SULFONYLUREAS plus METFORMIN IN TYPE 2 DIABETIC PATIENTS IN ITALY
    Lorenzoni, V
    Baccetti, F.
    Genovese, S.
    Torre, E.
    Veneziano, M. A.
    Crocchiolo, D.
    Turchetti, G.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A671 - A671
  • [10] Type 2 Diabetes Canagliflozin Plus Metformin as Initial Therapy promising
    Ruchalla, Elke
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (09)
12345